• Login
    View Item 
    •   RD&E Research Repository Home
    • All RD&E publications by year
    • 2021 RD&E publications
    • View Item
    •   RD&E Research Repository Home
    • All RD&E publications by year
    • 2021 RD&E publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial

    Thumbnail
    URI
    https://rde.dspace-express.com/handle/11287/621675
    Author
    Withers, Nicholas J.
    Date
    2021-02-01
    Journal
    American Journal of Respiratory and Critical Care Medicine
    Type
    Clinical Trial, Phase III
    Publisher
    Atypon
    DOI
    10.1164/rccm.202008-3176LE
    Rights
    Copyright © 1987-2020 American Thoracic Society, All Rights Reserved.
    Metadata
    Show full item record
    Citation
    Griese M et al. Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial. Am J Respir Crit Care Med. 2021 Feb 1;203(3):381-385.
    Publisher URL
    https://www.atsjournals.org/doi/10.1164/rccm.202008-3176LE?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
    Collections
    • 2021 RD&E publications
    • Respiratory Medicine

    Browse

    All of RD&E Research RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2021  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV